ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$2.87 USD
-0.01 (-0.35%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $2.86 -0.01 (-0.35%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/6/24 |
---|---|
Current Quarter | -0.44 |
EPS Last Quarter | -0.56 |
Last EPS Surprise | 0.00% |
ABR | 1.43 |
Earnings ESP
|
-2.27% |
---|---|
Current Year | -1.87 |
Next Year | -1.47 |
EPS (TTM) | -2.75 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 19.06M | 20.06M | 78.17M | 95.91M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 19.32M | 20.70M | 80.46M | 102.52M |
Low Estimate | 18.56M | 19.27M | 75.89M | 90.79M |
Year ago Sales | 19.28M | 14.49M | 69.56M | 78.17M |
Year over Year Growth Est. | -1.17% | 38.41% | 12.37% | 22.70% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.44 | -0.41 | -1.87 | -1.47 |
# of Estimates | 4 | 4 | 5 | 4 |
Most Recent Consensus | -0.43 | -0.40 | -2.16 | -1.65 |
High Estimate | -0.40 | -0.34 | -1.54 | -1.08 |
Low Estimate | -0.48 | -0.47 | -2.16 | -1.70 |
Year ago EPS | -0.58 | -0.58 | -2.94 | -1.87 |
Year over Year Growth Est. | 24.14% | 29.31% | 36.39% | 21.04% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 0 | 1 |
Down Last 30 Days | 1 | 1 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.44 | -0.41 | -1.87 | -1.47 |
7 Days Ago | -0.42 | -0.40 | -1.92 | -1.45 |
30 Days Ago | -0.42 | -0.40 | -1.92 | -1.45 |
60 Days Ago | -0.42 | -0.40 | -1.92 | -1.45 |
90 Days Ago | -0.56 | -0.55 | -2.20 | -1.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -0.44 | -1.87 | -1.52 |
Zacks Consensus Estimate | -0.44 | -0.41 | -1.87 | -1.47 |
Earnings ESP | -2.27% | -6.67% | -0.21% | -3.23% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.56 | -1.03 | -0.58 | -0.58 | NA |
Estimate | -0.56 | -0.47 | -0.61 | -0.44 | NA |
Difference | 0.00 | -0.56 | 0.03 | -0.14 | -0.17 |
Surprise | 0.00% | -119.15% | 4.92% | -31.82% | -36.51% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more